Novo Nordisk A/S

NYSE:NVO

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NVO's stock price target?

Price Target

51.192 USD

According to Wall Street analysts, the average 1-year price target for NVO is 51.192 USD with a low forecast of 31.009 USD and a high forecast of 73.178 USD.

What is the Revenue forecast for Novo Nordisk A/S?

Projected CAGR

3%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for Novo Nordisk A/S?

Projected CAGR

3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 3%.

What is the Operating Income forecast for Novo Nordisk A/S?

Projected CAGR

1%

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 1%.

What is the Pre-Tax Income forecast for Novo Nordisk A/S?

Projected CAGR

0%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 0%.

What is the Net Income forecast for Novo Nordisk A/S?

Projected CAGR

-1%

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is -1%.